Form 8-K - Current report:
SEC Accession No. 0001104659-24-002077
Filing Date
2024-01-08
Accepted
2024-01-08 08:10:38
Documents
54
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm242324d1_8k.htm   iXBRL 8-K 26764
2 EXHIBIT 99.1 tm242324d1_ex99-1.htm EX-99.1 59233
6 GRAPHIC tm242324d1_ex99-1img001.jpg GRAPHIC 161503
7 GRAPHIC tm242324d1_ex99-1img002.jpg GRAPHIC 335200
8 GRAPHIC tm242324d1_ex99-1img003.jpg GRAPHIC 177680
9 GRAPHIC tm242324d1_ex99-1img004.jpg GRAPHIC 170423
10 GRAPHIC tm242324d1_ex99-1img005.jpg GRAPHIC 210453
11 GRAPHIC tm242324d1_ex99-1img006.jpg GRAPHIC 212660
12 GRAPHIC tm242324d1_ex99-1img007.jpg GRAPHIC 220288
13 GRAPHIC tm242324d1_ex99-1img008.jpg GRAPHIC 174735
14 GRAPHIC tm242324d1_ex99-1img009.jpg GRAPHIC 219837
15 GRAPHIC tm242324d1_ex99-1img010.jpg GRAPHIC 166856
16 GRAPHIC tm242324d1_ex99-1img011.jpg GRAPHIC 210086
17 GRAPHIC tm242324d1_ex99-1img012.jpg GRAPHIC 193749
18 GRAPHIC tm242324d1_ex99-1img013.jpg GRAPHIC 164011
19 GRAPHIC tm242324d1_ex99-1img014.jpg GRAPHIC 228667
20 GRAPHIC tm242324d1_ex99-1img015.jpg GRAPHIC 206997
21 GRAPHIC tm242324d1_ex99-1img016.jpg GRAPHIC 132154
22 GRAPHIC tm242324d1_ex99-1img017.jpg GRAPHIC 172771
23 GRAPHIC tm242324d1_ex99-1img018.jpg GRAPHIC 184273
24 GRAPHIC tm242324d1_ex99-1img019.jpg GRAPHIC 151348
25 GRAPHIC tm242324d1_ex99-1img020.jpg GRAPHIC 166035
26 GRAPHIC tm242324d1_ex99-1img021.jpg GRAPHIC 153335
27 GRAPHIC tm242324d1_ex99-1img022.jpg GRAPHIC 190708
28 GRAPHIC tm242324d1_ex99-1img023.jpg GRAPHIC 230789
29 GRAPHIC tm242324d1_ex99-1img024.jpg GRAPHIC 157242
30 GRAPHIC tm242324d1_ex99-1img025.jpg GRAPHIC 237753
31 GRAPHIC tm242324d1_ex99-1img026.jpg GRAPHIC 166195
32 GRAPHIC tm242324d1_ex99-1img027.jpg GRAPHIC 172316
33 GRAPHIC tm242324d1_ex99-1img028.jpg GRAPHIC 195687
34 GRAPHIC tm242324d1_ex99-1img029.jpg GRAPHIC 156064
35 GRAPHIC tm242324d1_ex99-1img030.jpg GRAPHIC 185404
36 GRAPHIC tm242324d1_ex99-1img031.jpg GRAPHIC 191165
37 GRAPHIC tm242324d1_ex99-1img032.jpg GRAPHIC 165192
38 GRAPHIC tm242324d1_ex99-1img033.jpg GRAPHIC 193109
39 GRAPHIC tm242324d1_ex99-1img034.jpg GRAPHIC 201622
40 GRAPHIC tm242324d1_ex99-1img035.jpg GRAPHIC 975366
41 GRAPHIC tm242324d1_ex99-1img036.jpg GRAPHIC 175566
42 GRAPHIC tm242324d1_ex99-1img037.jpg GRAPHIC 169747
43 GRAPHIC tm242324d1_ex99-1img038.jpg GRAPHIC 200979
44 GRAPHIC tm242324d1_ex99-1img039.jpg GRAPHIC 169168
45 GRAPHIC tm242324d1_ex99-1img040.jpg GRAPHIC 340480
46 GRAPHIC tm242324d1_ex99-1img041.jpg GRAPHIC 305713
  Complete submission text file 0001104659-24-002077.txt   12391037

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA syn-20240108.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20240108_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20240108_pre.xml EX-101.PRE 22378
48 EXTRACTED XBRL INSTANCE DOCUMENT tm242324d1_8k_htm.xml XML 3324
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 24518444
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)